Philadelphia Positive Acute Lymphoblastic Leukemia
Oncology·MeSH: Blast Crisis
Prevalence
30.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Philadelphia Positive Acute Lymphoblastic Leukemia?
There are 2 clinical trials targeting Philadelphia Positive Acute Lymphoblastic Leukemia tracked by BioSniper.
What is the prevalence of Philadelphia Positive Acute Lymphoblastic Leukemia?
The estimated prevalence of Philadelphia Positive Acute Lymphoblastic Leukemia is approximately 30.0 per 100,000 population.
Deep-dive into Philadelphia Positive Acute Lymphoblastic Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis